BGB-24714

N/A

Report date: 2024/08/05 17:18:32
NME

Base Information

Drug NameBGB-24714
Drug Alias NameBGB-24714
ClassificationSmall molecules
Mechanisms of ActionCellular inhibitor of apoptosis protein 1 inhibitors
TargetsCellular inhibitor of apoptosis protein 1
Therapy Area/IndicationsSolid tumoursLung NeoplasmsEsophageal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeOne Medicines Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeigene (Suzhou) Biotechnology Co Ltd
Inactive CompaniesBeOne Medicines Ltd
Active IndicationsLung NeoplasmsEsophageal Neoplasms
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A